Anymedi Solution
Patient-specific surgical solutions for precise medicine
Gyeonggi-do, South Korea · Founded 2006 · $6.8M raised
- Headquarters
- Gyeonggi-do
- Founded
- 2006
- Business Model
- B2B
- Website
- anymedi.com
- Total Funding
- $6.8M
- Last Round
- $1.2M Series ANov 2017
- Rounds
- 3
About
Since 2006, Anymedi Solution has provided patient-specific surgical solutions leveraging cutting-edge technologies including AI, 3D printing, and cloud computing. The company has conducted over 2,000 clinical studies demonstrating the safety and effectiveness of its surgical solutions. Anymedi creates personalized medical materials and devices — including surgical implants and simulators — designed to replicate specific organs for training models and surgical planning. Its products primarily address complex procedures in congenital heart disease and other structural cardiac conditions, enabling surgeons to plan and practice patient-specific interventions before the operating room.
Summary
Anymedi Solution is a Biotech company based in Gyeonggi-do, South Korea, founded in 2006. It has raised $6.8M in total across 3 rounds, most recently a $1.2M Series A round in Nov 2017. Investors include SBI Investment Korea.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Nov 2017
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.

Specialty pharmaceutical company